UMIN ID: UMIN000000554
Registered date:25/12/2006
Clinical dose-escalation study of auto-gammadelta T cell therapy for multiple myeloma to investigate its safety and efficacy
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | Multiple myeloma |
| Date of first enrollment | 2006/09/01 |
| Target sample size | 6 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | Gammadelta T cell is to be administrated intravenously four times on a biweekly-basis. |
Outcome(s)
| Primary Outcome | Safety : Adverse events |
|---|---|
| Secondary Outcome | Efficacy : Improvement and maintenance of tumor-related immuno/biochemistrical parameters |
Key inclusion & exclusion criteria
| Age minimum | 20years-old |
|---|---|
| Age maximum | 75years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | Patients who have: uncontrolled infections, active autoimmune diseases, serious cardiac disease and other cancers; who have received continuous systemic steroids; who are pregnant, to be pregnant, or nursing mothers, and whom principle investigator or co-investigator judged to be inappropriate to participate in this study |
Related Information
| Primary Sponsor | Japanese Red Cross Medical Center |
|---|---|
| Secondary Sponsor | Sata Clinic |
| Source(s) of Monetary Support | Medinet Co.,Ltd |
| Secondary ID(s) |
Contact
| public contact | |
| Name | |
| Address | Japan |
| Telephone | 03-3400-1311 |
| Affiliation | Japanese Red Cross Medical Center Hematological Department |
| scientific contact | |
| Name | Kenshi Suzuki |
| Address | 4-1-22, Hiroo, Shibuya-ku, Tokyo, Japan Japan |
| Telephone | |
| Affiliation | Japanese Red Cross Medical Center Hematological Department |